VIOFORM-HYDOCORTISONE 3/1 %w/w %w/w Cream Ireland - English - HPRA (Health Products Regulatory Authority)

vioform-hydocortisone 3/1 %w/w %w/w cream

novartis consumer health uk limited - clioquinol hydrocortisone - cream - 3/1 %w/w %w/w

Betnovate C New Zealand - English - Medsafe (Medicines Safety Authority)

betnovate c

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative} (0.122% with overage); clioquinol 3%{relative} - topical ointment - active: betamethasone valerate 0.1%{relative} (0.122% with overage) clioquinol 3%{relative} excipient: liquid paraffin white soft paraffin - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.

ALA QUIN- hydrocortisone and iodochlorhydroxyquin cream United States - English - NLM (National Library of Medicine)

ala quin- hydrocortisone and iodochlorhydroxyquin cream

crown laboratories - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), clioquinol (unii: 7bhq856ej5) (clioquinol - unii:7bhq856ej5) - hydrocortisone 5 mg in 1 g - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: “possibly” effective: contact or atopic dermatitis; impetiginized eczema; nummular eczema; infantile eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. final classification of the less-than-effective indications requires further investigation. hypersensitivity to lodochlorhydroxyquin-hydrocortisone, or any of its ingredients or related compounds: lesions of the eye, tuberculosis of the skin; most viral skin lesions (including herpes simplex, vaccinia, and varicella). patients sensitive to chloroxine, iodine, or iodi

LOCACORTEN VIOFORM CREAM Kenya - English - Pharmacy and Poisons Board

locacorten vioform cream

amdipharm limited amdipharm limited, temple chambers, 3 burlington - flumetasone pivalate and clioquinol bp - cream - flumethasone pivalate 0.2% and clioquinol 3% - otological corticosteroids and anti-infectives in

LOCACORTEN VIOFORM EAR DROPS Ear Drops, Solution Kenya - English - Pharmacy and Poisons Board

locacorten vioform ear drops ear drops, solution

amdipharm limited amdipharm limited, temple chambers, 3 burlington - flumetasone pivalate and clioquinol bp - ear drops, solution - flumetasone pivalate 0.02% w/v and clioquinol bp… - ophthalmological and otological preparation:

NEO VAGEX TABLET Canada - English - Health Canada

neo vagex tablet

neolab inc - acetarsol; clioquinol; benzalkonium chloride - tablet - 100mg; 50mg; 2mg - acetarsol 100mg; clioquinol 50mg; benzalkonium chloride 2mg - miscellaneous antifungals

HYDRODERM-C CREAM 1% Singapore - English - HSA (Health Sciences Authority)

hydroderm-c cream 1%

icm pharma pte. ltd. - clioquinol; hydrocortisone acetate - cream - 3% w/w - clioquinol 3% w/w; hydrocortisone acetate 1% w/w